The Last Mile:
Impotent Vaccines
More than 3 million people die from vaccine-preventable diseases each year. Approximately 1.5 million of these deaths are in children less than 5 years old, one death almost every 20 seconds. Sadly, many of these deaths are due to failures along with the vaccine cold chain in poor and developing countries.
Most vaccines must be kept between 2 and 8 Centigrade to remain active. In countries like the US, this is not a problem because of advanced refrigeration techniques and ready access to electricity. However, the Global Alliance for Vaccines and Immunization (GAVI) estimates that only 10% of health care facilities in the world’s poorest countries have a reliable electricity supply.
"Vaccines are often out of potency before they even arrive"
Harvey Rubin,
Professor at the University of Pennsylvania
Our Strength
Using Penn-developed Energy Harvesting Technologies, TemPower can actively monitor the temperature change and maintain a cool environment without being charged. The cold life can be as long as several weeks while maintaining a low price.
Data Logger & GPS Tracker
TemPower Carrier is the only product that offers GPS and temperature tracker. This allows healthcare workers to better allocate vaccines, prevent wastage, and protect patients from getting falsely "potent" vaccines.
Active Cooling/Heating
Overheating and freezing of the vaccine during transportation is the biggest reason for cold-chain failure. While competitive products rely on ice to passively cool down, TemPower uses a heating chip to actively control the temperature of the carrier. Energy Harvested from our unique technology can sustain a cold life over a week.
Easy-to-Use
Without using ice packs and heavy insulations, TemPower is about 3 times smaller than competitive products. This makes TemPower highly portable.
Moreover, TemPower is easy to use and does not require pre-cooling, It can be applied to all scenarios immediately.
OUR TEAM
We are a group of aspiring students at the University of Pennsylavania
Read More
